返回 
加入收藏
我国医疗机构药学监护开展现状调查
x
请在关注微信后，向客服人员索取文件
| 篇名： | 我国医疗机构药学监护开展现状调查 |
| TITLE： | Investigation on the current status of pharmaceutical care in medical institutions in China |
| 摘要： | 目的 调查我国医疗机构药学监护开展现状，为药学监护持续发展提供经验和建议。方法采用问卷调查法，于2023年3月调研31个省（自治区、直辖市）医疗机构药学监护的开展情况，对结果进行描述性分析，并对药学监护开展的影响因素进行二元Logistic回归分析。结果共发放问卷1368份，收回有效问卷1304份，问卷有效回收率为95.32%。有671家（51.46%）医疗机构开展了药学监护，其中三级、二级、一级及其他医疗机构药学监护开展率分别为74.79%、27.97%、7.35%。平均年药学监护服务患者量为2638.96人次，平均每家医疗机构有8.33名药师开展药学监护，开展药学监护药师中有93.68%是临床药师。药学监护服务覆盖的主要科室包括呼吸与危重症医学科、心内科、重症医学科、内分泌科、肿瘤科、消化内科、妇产科等。对药学监护服务有额外补偿的医疗机构为48家（7.15%）。开展药学监护的主要经验是重视人才培养和重视学科建设，面临的主要困难是人员短缺、符合要求的人才严重不足和补偿水平低、开展的积极性不高。医疗机构等级、医疗机构从事临床药学工作的药师数量、医疗机构有临床药师资质的药师数量以及医疗机构药学部信息化程度是开展药学监护的主要影响因素（P＜0.05）。结论近年来我国医疗机构药学监护取得了一定进展，但一、二级及其他医疗机构药学监护开展率仍有较大的提升空间。后续仍需进一步推进药学监护开展、加强人才培养、重视药学监护价值体现，进而促进药学监护可持续、高质量发展。 |
| ABSTRACT： | OBJECTIVE To investigate the current status of pharmaceutical care in medical institutions in China， and provide experience and suggestions for better development of pharmaceutical care. METHODS Questionnaire survey was used to investigate the development of pharmaceutical care in medical institutions in 31 provinces （autonomous regions and municipalities directly） in March 2023， and descriptive analysis and binary logistic regression analysis on the influencing factors of pharmaceutical care were conducted. RESULTS A total of 1 368 questionnaires were sent out， and 1 304 valid questionnaires were collected with the effective recovery rate of 95.32%. Pharmaceutical care was carried out in 671 medical institutions （51.46%）， and the rates of pharmaceutical care in tertiary， secondary， primary and other medical institutions were 74.79%， 27.97% and 7.35%， respectively. The average number of patients receiving pharmaceutical care was 2 638.96 per year， and there were 8.33 pharmacists in each medical institution to carry out pharmaceutical care， among which 93.68% were clinical pharmacists. The main departments covered by pharmaceutical care services included respiratory and critical care medicine， cardiology， intensive care unit， endocrinology， oncology， gastroenterology， obstetrics and gynecology and other departments. There were only 48 medical institutions （7.15%） with additional compensation for pharmaceutical care services. The main experiences of developing pharmaceutical care were to pay attention to talent cultivation and discipline construction， but the main difficulties were serious shortage of staff and qualified talents， low compensation level and low enthusiasm. Grade of medical institutions， the number of pharmacists engaged in clinical pharmacy， the number of qualified clinical pharmacists and the degree of information in the pharmacy department were the main influencing factors for carrying out pharmaceutical care （P＜0.05）. CONCLUSIONS In recent years， pharmaceutical care in Chinese medical institutions has made certain progress， while that of primary medical institutions， secondary medical institutions and other medical institutions should be improved. In the future， it is still necessary to further enhance the implementation of pharmaceutical care， promote personnel training， and attach importance to demonstrating the value of pharmaceutical care， thereby promoting the sustainable and high- quality development of pharmaceutical care. |
| 期刊： | 2025年第36卷第09期 |
| 作者： | 郑婷婷；张宇晴；刘思彤；张威；陆进；沈群红；甄健存 |
| AUTHORS： | ZHENG Tingting，ZHANG Yuqing，LIU Sitong，ZHANG Wei，LU Jin，SHEN Qunhong，ZHEN Jiancun |
| 关键字： | 药学监护；现状；问卷调查；影响因素 |
| KEYWORDS： | pharmaceutical care； current status； questionnaire survey； influencing factors |
| 阅读数： | 9 次 |
| 本月下载数： | 3 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
